Jung, Susanne
Bosch, Agnes
Ott, Christian
Kannenkeril, Dennis
Dienemann, Thomas
Harazny, Joanna M. http://orcid.org/0000-0003-0124-0543
Michelson, Georg
Schmieder, Roland E.
Funding for this research was provided by:
Novartis | Novartis Pharma (3006261)
Article History
Received: 14 August 2019
Accepted: 4 February 2020
First Online: 24 March 2020
Competing interests
: R.E.S. is a state employee of the Free State of Bavaria (University Hospital Erlangen)/Federal Republic of Germany. He is a member of the working group of 2013/2018 ESC/ESH guidelines for the management of arterial hypertension. R.E.S. received Speaker fees, Consultancy and Advisory Board fees from Bayer, Berlinchemie, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, Novartis, Recor, ROX Medical and Servier. Research grant to the institution has been given to RES by DFG, Amgen, Ablative Solutions, Boehringer Ingelheim, Novartis, Medtronic, Recor and ROX Medical. All other authors have no conflicts of interest to declare.